Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising outcomes. However, the cost of this innovative drug and its supply have become key topics for patients and healthcare practitioners. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant challenge to m